Overweight with HBV infection limited the efficacy of TACE in hepatocellular carcinoma by inhibiting the upregulated HMGB1

Table 2 Clinical characteristics of patients

Parameters	Group1^a (n = 57)	Group2^b (n = 221)	Group3^c (n = 58)	Group4^d (n = 107)	F	P
Age (mean ± SD)	60.67 ± 12.01	57.12 ± 9.31	57.07 ± 11.12	55.48 ± 9.62	3.342	0.019
Sex					2.315	0.075
Male	52	194	44	91
Female	5	27	14	16
PVTT^e					0.585	0.625
Yes	11	44	16	23
No	46	177	42	84
BCLC^f					0.027	0.994
A	10	27	8	15
B	32	147	34	68
C	15	47	16	24
Child–Pugh					3.150	0.025
A	22	41	20	33
B	35	179	38	74
C	0	1	0	0
Milan criteria					1.101	0.348
Yes	14	79	20	41
No	43	142	38	66
Total tumor diameter (mm)					2.740	0.043
< 30	5	43	8	19
30–50	10	57	14	32
> 50	42	121	36	56
Number of lesions					3.230	0.22
1	50	161	50	87
2	1	12	2	6
≥ 3	6	48	6	14

ISSN: 1471-2407